Richard Levine, MD, performed the procedure at MedStar Surgery Center at Timonium (Md.), an ASC affiliated with Medstar Union Memorial Hospital.
The implant is used to treat anterior cruciate ligament tears. Before the implant, surgeons had to surgically reconstruct a patient’s ACL. Miach Orthopaedics initiated the BEAR III study to continue to build upon the extensive base of evidence for the BEAR Implant.
The FDA granted de novo clearance for the device in December. The implant restores natural anatomy and function of the knee, is less invasive and doesn’t require surgeons to remove a tendon like reconstruction does.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
